Author

M. Reed

Medical University of Vienna

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1 Immunology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

A. Baugh· 1 shared A. D. Beale· 1 shared A. Jongkaewwattana· 1 shared A. Paravati· 1 shared A. Stangherlin· 1 shared A. Thitithanyanont· 1 shared A. Zeng· 1 shared B. Nakamura· 1 shared

Activity by Year

2020-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 8 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Baugh

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Subacute effects of ketamine on neural correlates of reward processing

Elisa Briem, Peter Stöhrmann, Gregor Dörl, Christian Milz, Gabriel Schlosser, Manfred Klöbl, M. Reed, Matthieu Atger, Claudia Schmidt, Samantha Graf, Maximilian Kathofer, Godber Mathis Godbersen, J. Crone, Rupert R. Lanzenberger, Marie Spies

This study examines ketamine's subacute effects on reward processing using fMRI and finds no significant modulation of neural activation during the MID task five hours post-infusion.

Translational Psychiatry · Sep 24, 2026Peer-reviewedNeuroscience

CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines.

M. Garrett, T. Carnwath, R. Albano, Y. Zhuang, C. A. Behrmann, M. Pemberton, F. Barakat, R. Lober, M. Hoeprich, A. Paravati, M. Reed, H. Spry, D. Woo, E. O'Brien, B. VanCauwenbergh, , D. Plas

This study identifies CPI203, a BET inhibitor, as a compound that consistently down-regulates DNA synthesis genes across multiple glioblastoma lines.

bioRxiv · Jun 26, 2024Cancer Biology

Targeting MDSC-HTR2B to Improve Immune Checkpoint Inhibitors in Breast to Brain Metastasis

M. Iyer, D. Das, A. Baugh, P. Shah, B. Nakamura, S. Sedighi, M. Reed, J. Jang, F. Chow, E. R. Torres, J. Neman

The paper identifies HTR2B on MDSCs as a target to enhance immune checkpoint inhibitors in breast-to-brain metastasis using clozapine and anti-PD-1 therapy.

bioRxiv · Jun 20, 2024 · PreprintCancer Biology

Immunogenicity and Protective Efficacy of a SARS-CoV-2 mRNA Vaccine Encoding Secreted Non-Stabilized Spike Protein in Mice

E. Prompetchara, C. Ketloy, M. G. Alameh, K. Tarakhet, P. Kaewpang, N. Yostrerat, P. Pitakpolrat, S. Buranapraditkun, S. Manopwisedcharoen, A. Thitithanyanont, A. Jongkaewwattana, T. Hunsawong, R. Im-Erbsin, M. Reed, W. Wijagkanalan, , K. Ruxrungtham

This paper evaluates a SARS-CoV-2 mRNA vaccine in mice, showing strong neutralizing antibody and T cell responses, better cross-neutralization against variants, and protective efficacy against infection.

bioRxiv · Sep 7, 2022 · PreprintImmunology

CRYPTOCHROME suppresses the circadian proteome and promotes protein homeostasis

D. C. S. Wong, E. Seinkmane, A. Stangherlin, A. Zeng, N. M. Rzechorzek, A. D. Beale, J. Day, M. Reed, S. Y. Peak-Chew, C. T. Styles, R. S. Edgar, M. Putker, J. S. O'Neill

This study compares the circadian proteome and phosphoproteome of wild-type and CRY-deficient fibroblast cells, finding increased circadian-regulated proteins and stress sensitivity in CRY-deficient cells.

bioRxiv · May 16, 2020Cell Biology